Dialysis Clinical Outcomes Revisited (DCOR) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

February 28, 2006

Conditions
Chronic Kidney Disease
Interventions
DRUG

Sevelamer hydrochloride

DRUG

Calcium-based phosphate binder

Trial Locations (73)

19141

Albert Einstein Medical Center, Philadelphia

22902

Gambro Healthcare - Charlottesville, Charlottesville

23298

Virginia Commonwealth University, Division of Nephrology, Richmond

23507

Clinical Research of Tidewater, Norfolk

39705

Nephrology Associates, P.C., Columbus

45220

Kidney and Hypertension Center, Cincinnati

Unknown

Gambro Healthcare-Gadsden, Gadsden

nTouch Research, Huntsville

Kidney Health Institute, LLC, Tucson

Gambro Healthcare, El Cerrito

Palomar Medical Group, Escondido

Gambro Healthcare-Los Angeles, Los Angeles

Balboa Nephrology Medical Group, San Diego

Nephrology Educational Services and Research, Tarzana

Lowry Dialysis Center, Denver

Nephrology Associates, P.C., Bridgeport

Gambro Healthcare-Hartford, Hartford

Nephrology Associates, New Britain

InterAmerican Dialysis, Coral Gables

DaVita Crystal River Dialysis, Crystal River

Gambro Healthcare-Miami, Miami

Miami Kidney Group, Miami

Pensacola Nephrology, P.A., Pensacola

Gambro Healthcare-Plantation, Plantation

America Dialysis, St. Petersburg

Genesis Clinical Research Corp, Tampa

Gambro Healthcare-Americus, Americus

nTouch Research, Atlanta

Gambro Healthcare-Douglas, Douglas

Gambro Healthcare-Douglasville, Douglasville

Dublin Nephrology, Dublin

Georgia Kidney Associates, Inc., Marietta

Gambro Healthcare-Rome, Rome

Gambro Healthcare-Savannah, Savannah

MacNeal Renal Lifeline Services, Berwyn

Southwest Nephrology, Evergreen Park

Horizon Healthcare Associates, Olympia Fields

Renal Care Associates, S.C., Peoria

Gambro Healthcare-Springfield Central, Springfield

Lincolnland Dialysis, Springfield

Nephrology Specialists, PC., Valparaiso

Wichita Dialysis Center East, Wichita

Wichita Nephrology, Wichita

Northwest Louisiana Nephrology, LLC., Shreveport

BMA of Washington, Bethesda

Gambro Healthcare-Frederick, Frederick

Associates in Nephrology, P.C., Brockton

Western New England Renal and Transplant Associates, Inc., Springfield

DaVita Clinical Research, Minneapolis

University of Missouri-Kansas City, Kansas City

DaVita Crystal City Dialysis, St Louis

Nephrology and Endocrine Associates, Las Vegas

Bronx Westchester Medical Group, The Bronx

Mountain Kidney Associates, P.A., Asheville

nTouch Research, Raleigh

Wake Nephrology/Wake Dialysis Clinic, Raleigh

Gambro Healthcare-Wilson, Wilson

Ohio State University College of Pharmacy, Columbus

FMC of Bethlehem, Allentown

Fresenius Medical Care, Greensburg

Hypertension and Kidney Specialists, Lancaster

DaVita Lewistown Dialysis Center, Lewistown

P.C. & Associates, Philadelphia

Nesbitt College of Pharmacy and Nursing Department of Pharmacy Practice, Wilkes-Barre

Gambro Healthcare-Aiken, Aiken

Midsouth Nephrology Consultants, Memphis

Dallas Nephrology Associates, Dallas

Nephrology, Dialysis and Transplant Association, Houston

West Houston Dialysis, Houston

San Antonio Kidney Disease Center, San Antonio

Clinical Research and Consulting Center, LLC, Fairfax

Vancouver Clinic Inc., P.S., Vancouver

Clinical Las Americas, San Juan

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00324571 - Dialysis Clinical Outcomes Revisited (DCOR) Trial | Biotech Hunter | Biotech Hunter